Clinical correlates of atypical femoral fracture

Bone

Volumn 51, Issue 1, 2012, Pages 181-184

  Lo, Joan C ^a,b   Huang, Susie Y ^b   Lee, Grace A ^b   Khandewal, Stutee ^b   Provus, Jason ^c   Ettinger, Bruce ^a   Gonzalez, Joel R ^a   Hui, Rita L ^c   Grimsrud, Christopher D ^b  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Asian women; Atypical fracture; Bisphosphonates; Femur fracture; Osteoporosis

Indexed keywords

ALENDRONIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BONE RADIOGRAPHY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; FEMALE; FEMUR FRACTURE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RACE DIFFERENCE; STRESS FRACTURE; TREATMENT DURATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; HIP FRACTURES; HUMANS; MIDDLE AGED;

EID: 84861813984     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.632     Document Type: Article

References (18)

1. Shane E., Burr D., Ebeling P.R., et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010, 25(11):2267-2294.
2. Goh S.K., Yang K.Y., Koh J.S., et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 2007, 89(3):349-353.
3. Neviaser A.S., Lane J.M., Lenart B.A., Edobor-Osula F., Lorich D.G. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008, 22(5):346-350.
4. Abrahamsen B., Eiken P., Eastell R. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab 2010, 95(12):5258-5265.
5. Black D.M., Kelly M.P., Genant H.K. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 2010, 362(19):1761-1771.
6. Tan S.C., Koh S.B., Goh S.K., Howe T.S. Atypical femoral stress fractures in bisphosphonate-free patients. Osteoporos Int 2011, 22(7):2211-2212.
7. Huang S.Y., Grimsrud C.D., Provus J., et al. The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int 2012, 23(2):743-750.
8. Gordon N.P. Similarity of the Kaiser Permanente Senior Member Population in Northern California to the Non-Kaiser Permanente Covered and General Population of Seniors in Northern California: statistics from the 2009 California Health Interview Survey. Internal Division of Research report 2012, Accessed February 17, 2012. http://www.dor.kaiser.org/external/chis_kpnc_seniors_2009/.
9. United States Census Bureau Overview of Race and Hispanic Origin: 2010 2011, Accessed February 15, 2012, 2012. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf.
10. Nieves J.W., Bilezikian J.P., Lane J.M., et al. Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int 2010, 21(3):399-408.
11. Kwek E.B., Goh S.K., Koh J.S., Png M.A., Howe T.S. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury 2008, 39(2):224-231.
12. Schilcher J., Michaëlsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011, 364(18):1728-1737.
13. Giusti A., Hamdy N.A., Dekkers O.M., Ramautar S.R., Dijkstra S., Papapoulos S.E. Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 2011, 48(5):966-971.
14. Armamento-Villareal R., Napoli N., Diemer K., et al. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Calcif Tissue Int 2009, 85(1):37-44.
15. Odvina C.V., Levy S., Rao S., Zerwekh J.E., Rao D.S. Unusual mid-shaft fractures during long-term bisphosphonate therapy. Clin Endocrinol (Oxf) 2010, 72(2):161-168.
16. Cummings S.R., Cauley J.A., Palermo L. Racial differences in hip axis lengths might explain racial differences in rates of hip fracture. Study of Osteoporotic Fractures Research Group. Osteoporos Int 1994, 4(4):226-229.
17. Nakamura T., Turner C.H., Yoshikawa T., et al. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans?. J Bone Miner Res 1994, 9(7):1071-1076.
18. Tang W.M., Chiu K.Y. Variances in sagittal femoral shaft bowing in patients undergoing TKA. Clin Orthop Relat Res 2008, 466(4):1008-1009.